25I vs 4BB: Side-by-Side Comparison
Compare IMMUPHARMA PLC LS-01 (25I) and 4BASEBIO UK SOCIETAS (4BB) side by side: market cap EUR 14.35M vs GBX 8.13B. Financials, growth and model signals on Bullrun.
| Metric | 25I | 4BB |
|---|---|---|
| Company | IMMUPHARMA PLC LS-01 | 4BASEBIO UK SOCIETAS |
| Country / Exchange | United Kingdom · F | United Kingdom · LSE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 14.35M | GBX 8.13B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2024) | EUR 0 | GBP 933.00K |
| Revenue growth YoY | — | +84.4% |
| Net income | EUR -2.48M | GBP -12.33M |
| Gross margin | — | 67.5% |
| Diluted EPS | -0.01 | -0.94 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.